Aldosterone to renin ratio in a primary care setting: The Bussolengo study

Journal of Clinical Endocrinology and Metabolism

Volumn 89, Issue 9, 2004, Pages 4221-4226

  Olivieri, Oliviero ^a,c   Ciacciarelli, Alberto ^b   Signorelli, Denise ^c   Pizzolo, Francesca ^a   Guarini, Patrizia ^a   Pavan, Chiara ^a   Corgnati, Angela ^a   Falcone, Salvatore ^c   Corrocher, Roberto ^a   Micchi, Alessio ^b   Cressoni, Chiara ^b   Blengio, Gianstefano ^c  

^a UNIVERSITY OF VERONA   (Italy)

^b Bussolengo Health District ^*

^c POLICLINICO BORGO ROMA   (Italy)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE; ALPHA ADRENERGIC RECEPTOR BLOCKING AGENT; RENIN; VERAPAMIL;

ADULT; AGED; ALDOSTERONE BLOOD LEVEL; ARTICLE; DEMOGRAPHY; DISEASE ASSOCIATION; FEMALE; GENERAL PRACTITIONER; HUMAN; HYPERTENSION; MAJOR CLINICAL STUDY; MALE; PLASMA RENIN ACTIVITY; PREVALENCE; PRIMARY MEDICAL CARE; PRIORITY JOURNAL; RANDOMIZATION; SCREENING TEST; STANDING; STATISTICAL ANALYSIS;

ADULT; AGE FACTORS; AGED; ALDOSTERONE; FEMALE; HUMANS; HYPERTENSION; ITALY; MALE; MIDDLE AGED; RENIN; SEX FACTORS;

EID: 4544267585     PISSN: 0021972X     EISSN: None     Source Type: Journal    
DOI: 10.1210/jc.2003-032179     Document Type: Article

References (35)

1. Hiramatsu K, Yamada T, Yukimura Y, Komiya I, Ichikawa K, Ishihara M, Nagata H, Izumiyama T 1981 A screening test to identify aldosterone-producing adenoma by measuring plasma renin activity. Arch Intern Med 141:1589-1593
2. Hamlet SM, Tunny TJ, Woodland E, Gordon RD 1985 Is the aldosterone/renin ratio useful to screen a hypertensive population for primary aldosteronism? Clin Exp Pharmacol Physiol 12:249-252
3. McKenna TJ, Sequeira SJ, Heffernan A, Chambers J, Cunningham S 1991 Diagnosis under random conditions of all disorders of the renin-angiotensin- aldosterone axis, including primary aldosteronism. J Clin Endocrinol Metab 73:952-957
4. Gordon RD, Ziezak MD, Tunny TJ, Stowasser M, Klemm SA 1993 Evidence that primary aldosteronism may not be uncommon: twelve percent incidence among antihypertensive drug trial volunteers. Clin Exp Pharmacol Physiol 20:296-298
5. Gordon RD, Stowasser M, Tunny TJ, Klemm SA, Rutherford JC 1994 High incidence of primary aldosteronism in 199 patients referred with hypertension. Clin Exp Pharmacol Physiol 21:315-318
6. Brown MA, Cramp HA, Zammit VC, Whitworth JA 1996 Primary aldosteronism: a missed diagnosis in "essential hypertensives?" Aust NZ J Med 26:533-538
7. Young Jr WF 1997 Primary aldosteronism: update on diagnosis and treatment, Endocrinologist 7:213-221
8. Lim PO, Rodgers P, Cardale K, Watson AD, MacDonald TM 1999 Potentially high prevalence of primary aldosteronism in a primary-care population. Lancet 353:40
9. Kreze Jr A, Okalova D, Vanuga P, Putz Z, Kodaj J, Hrnciar J 1999 Occurrence of primary aldosteronism in a group of ambulatory hypertensive patients. Vnitr Lek 45:17-21
10. Mosso L, Fardella C, Montero J, Rojas P, Sanchez O, Rojas V, Rojas A, Huete A, Soto J, Foradori A 1999 High prevalence of undiagnosed primary hyperaldosteronism among patients with essential hypertension. Rev Med Child 127:800-806
11. Fardella CE, Mosso L, Gomez-Sanchez CE, Cortes P, Soto J, Gomez L, Pinto M, Houete A, Oestreicher E, Foradori A, Montero J 2000 Primary aldosteronism in essential hypertensives: prevalence, biochemical profile and molecular biology. J Clin Endocrinol Metab 85:1863-1867
12. Loh K-C, Koay ES, Khaw M-C, Emmanuel SC, Young WF 2000 Prevalence of primary aldosteronism among Asian hypertensive patients in Singapore. J Clin Endocrinol Metab 85:2854-2859
13. Gallay BJ, Ahmad S, Xu L, Toivola B, Davidson RC 2001 Screening for primary aldosteronism without discontinuing hypertensive medications: plasma aldosterone-renin ratio. Am J Kidney Dis 37:699-705
14. Rayner BL, Opie LH, Davidson JS 2000 The aldosterone/renin ratio as a screening test for primary aldosteronism. S Afr Med J 90:394-400
15. Trenkel S, Seifarth C, Schobel H, Hahn EG, Hensen J 2002 Ratio of serum aldosterone to plasma renin concentration in essential hypertension and primary aldosteronism. Exp Clin Endocrinol Diabetes 110:80-85
16. Stowasser M, Gordon RD 2001 Prevalence and diagnostic workup of primary aldosteronism: new knowledge and new approaches. Nephrology 6:119-126
17. Young WF 2003 Minireview: primary aldosteronism-changing concepts in diagnosis and treatment. Endocrinology 114:2208-2213
18. Lim PO, Jung RT, MacDonald TM 1999 Raised aldosterone to renin ratio predicts antihypertensive efficacy of spironolactone: a prospective cohort follow-up study. Br J Clin Pharmacol 48:756-760
19. Lim PO, Young WF, MacDonald TM 2001 A review of the medical treatment of primary aldosteronism. J Hypertension 19:353-361
20. Stowasser M 2000 Primary aldosteronism: revival of a syndrome. J Hypertension 18:363-366
21. Wolf-Maier K, Cooper RS, Banegas JR, Giampaoli S, Hense HW, Joffres M, Kastarinen M, Poulter N, Primatesta P, Rodriguez-Artalejo F, Stegmayr B, Thamm M, Tuomilehto J, Vanuzzo D, Vescio F 2003 Hypertension prevalence and blood pressure levels in 6 European countries, Canada, and the United States. JAMA 289:2363-2369
22. Mulatero P, Rabbia F, Milan A, Paglieri C, Morellow F, Chiandussi L, Veglio F 2002 Drug effects on aldosterone/plasma renin activity ratio in primary aldosteronism. Hypertension 40:897-902
23. Montori VM, Young Jr WF 2002 Use of plasma aldosterone concentration-to-plasma renin activity ratio as a screening test for primary aldosteronism. A systematic review of the literature. Endocrinol Metab Clin North Am 31:619-632
24. Montori VM, Schwarz GL, Chapman AB, Boerwinkle E, Turner ST 2001 Validity of the aldosterone-renin ratio used to screen for primary aldosteronism. Mayo Clin Proc 877-872
25. Schwartz GL, Chapman AB, Boerwinkle E, Kisabeth RM, Turner ST 2002 Screening for primary aldosteronism: implications of an increased plasma aldosterone/renin ratio. Clin Chem 48:1919-1923
26. Calhoun DA, Nishizaka MK, Zaman MA, Thakkar BB, Weissman P 2002 Hyperaldosteronism among black and white subjects with resistant hypertension. Hypertension 40:892-896
27. Kaplan NM 2001 Cautions over the current epidemic of primary aldosteronism. Lancet 357:953-954
28. Stowasser M, Gordon RD 2000 Primary aldosteronism: learning from the study of familial varieties. J Hypertension 18:1165-1176
29. Stowasser M, Bachmann AW, Huggard PR, Rossetti TR, Gordon RD 2000 Severity of hypertension in familial hyperaldosteronism type I: relationship to gender and degree of biochemical disturbance. J Clin Endocrinol Metab 85:2160-2166
30. Mulatero P, Morra di Cella S, Williams TA, Milan A, Mengozzi G, Chiandussi L, Gomez-Sanchez CE, Veglio F 2002 Glucocorticoid remediable aldosteronism: low morbidity and mortality in a four-generation Italian pedigree. J Clin Endocrinol Metab 87:3187-3191
31. Ulmer PS, Meikle AW 2000 Sample requirements for plasma renin activity and immunoreactive renin. Clin Chem 46:1442-1444
32. Morganti A, Pelizzola D, Mantero F, Gazzano G, Opocher G, Piffanelli A 1995 Immunoradiometric versus enzymatic renin assay: results of the Italian Multicentric Comparative Study. J Hypertens 13:19-26
33. Deinum J, Derkx FHM, Schalekamp MADH 1999 Improved immunoradiometric assay for plasma renin. Clin Chem 45:847-854
34. Lim PO, Macdonald TM, Holloway C, Friel E, Anderson NH, Dow E, Jung RT, Davies E, Fraser R, Connel JMC 2002 Variation at the aldosterone synthase (CYP11B2) locus contributes to hypertension in subjects with a raised aldosterone-to-renin ratio. J Clin Endocrinol Metab 87:4398-4402
35. Nicod J, Bruhin D, Auer L, Vogt B, Frey FJ, Ferrari P 2003 A biallelic gene polymorphism of CYP11B2 predicts increased aldosterone to renin ratio in selected hypertensive patients. J Clin Endocrinol Metab 88:2495-2500